» Articles » PMID: 29168741

Dose-Dependent Effects of Oral Tyrosine Administration on Plasma Tyrosine Levels and Cognition in Aging

Overview
Journal Nutrients
Date 2017 Nov 24
PMID 29168741
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of tyrosine on plasma response and cognition in aging are unknown. We assessed the dose-dependent response to tyrosine administration in older adults in both plasma tyrosine concentrations and working memory performance. In this double blind randomized cross-over trial 17 older adults (aged 60-75 years) received a single administration of 100, 150, or 200 mg/kg body weight of tyrosine. For comparison, 17 young adults (aged 18-35 years) received a dose of 150 mg/kg body weight of tyrosine. Tyrosine plasma concentrations were determined before and 90, 120, 150, 180, 210, and 240 min after tyrosine intake. Working memory was assessed using the N-back task at 90 min after tyrosine administration. Older adults showed a dose-dependent increase in plasma tyrosine concentrations ( < 0.001), and the plasma response was higher than for young adults with the same dose ( < 0.001). Load-dependent working memory performance decreased with higher doses of tyrosine ( = 0.048), especially in older adults with greater dose-dependent plasma tyrosine responses ( = 0.035). Our results show an age-related increase in plasma tyrosine response, which was associated with a dose-dependent decline in cognitive functioning in older adults.

Citing Articles

Association between large neutral amino acids and white matter hyperintensities in middle-aged adults at varying metabolic risk.

Youn C, Caillaud M, Li Y, Gallagher I, Strasser B, Tanaka H Brain Imaging Behav. 2024; 18(6):1448-1456.

PMID: 39331346 DOI: 10.1007/s11682-024-00937-z.


Large Neutral Amino Acids Moderate the Effects of Metabolic Syndrome on Cognitive Performance in Middle-Aged Adults.

Youn C, Caillaud M, Li Y, Gallagher I, Strasser B, Fuchs D Ann Nutr Metab. 2024; 80(4):226-234.

PMID: 38531323 PMC: 11305933. DOI: 10.1159/000538273.


L-Tyrosine Limits Mycobacterial Survival in Tuberculous Granuloma.

Gao Y, Li J, Guo X, Guan L, Wang J, Huang X Pathogens. 2023; 12(5).

PMID: 37242324 PMC: 10221957. DOI: 10.3390/pathogens12050654.


The catecholamine precursor Tyrosine reduces autonomic arousal and decreases decision thresholds in reinforcement learning and temporal discounting.

Mathar D, Erfanian Abdoust M, Marrenbach T, Tuzsus D, Peters J PLoS Comput Biol. 2022; 18(12):e1010785.

PMID: 36548401 PMC: 9822114. DOI: 10.1371/journal.pcbi.1010785.


Adequacy of nitisinone for the management of alkaptonuria.

Abbas K, Basit J, Ur Rehman M Ann Med Surg (Lond). 2022; 80:104340.

PMID: 36045846 PMC: 9422360. DOI: 10.1016/j.amsu.2022.104340.


References
1.
Turner G, Nathan Spreng R . Executive functions and neurocognitive aging: dissociable patterns of brain activity. Neurobiol Aging. 2011; 33(4):826.e1-13. DOI: 10.1016/j.neurobiolaging.2011.06.005. View

2.
Fernstrom J . Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev. 1983; 63(2):484-546. DOI: 10.1152/physrev.1983.63.2.484. View

3.
Sved A, Fernstrom J, Wurtman R . Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1979; 76(7):3511-4. PMC: 383857. DOI: 10.1073/pnas.76.7.3511. View

4.
Matthews D . An overview of phenylalanine and tyrosine kinetics in humans. J Nutr. 2007; 137(6 Suppl 1):1549S-1555S. PMC: 2268015. DOI: 10.1093/jn/137.6.1549S. View

5.
Caballero B, Gleason R, Wurtman R . Plasma amino acid concentrations in healthy elderly men and women. Am J Clin Nutr. 1991; 53(5):1249-52. DOI: 10.1093/ajcn/53.5.1249. View